BONE MARROW TRANSPLANT REJECTION

Clinical trials for BONE MARROW TRANSPLANT REJECTION explained in plain language.

Never miss a new study

Get alerted when new BONE MARROW TRANSPLANT REJECTION trials appear

Sign up with your email to follow new studies for BONE MARROW TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for High-Risk transplant patients

Disease control Recruiting now

This early study is testing if a drug called Darzalex Faspro can safely lower harmful antibodies in patients with blood cancers. Lowering these antibodies may allow patients who are currently ineligible to receive a potentially life-saving stem cell transplant from a donor. The s…

Matched conditions: BONE MARROW TRANSPLANT REJECTION

Phase: EARLY_PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

BONE MARROW TRANSPLANT REJECTION

Get alerted when new BONE MARROW TRANSPLANT REJECTION trials appear

New hope for High-Risk transplant patients